Level of Sialylation and Galactosylation of Blood Plasma Glycoproteins Under the Influence of Alkylating Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Studia Biologica
doi 10.30970/sbi.0702.293
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivan Franko National University of Lviv

Related search

Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Chronic Lymphocytic Leukemia（CLL）Patients in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Myocardial Contractility Dysfunction in Patients With Chronic Lymphocytic Leukemia Receiving Chemotherapy and Their Treatment With Enalapril

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2020English

Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide

Clinical Journal of Oncology Nursing
Oncology
2010English

Cell-Free IgG-aggregates in Plasma of Patients With Chronic Lymphocytic Leukemia Cause Chronic Activation of the Classical Complement Pathway

PLoS ONE
Multidisciplinary
2020English

The Impacts of Zanubrutinib on Immune Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Real World Outcomes of Obinutuzumab Monotherapy in Patients With Chronic Lymphocytic Leukemia

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Evaluation of Periodontal Parameters in Patients With Early Stage Chronic Lymphocytic Leukemia

Acta Stomatologica Croatica
Dentistry
2016English

Treatment of Patients With Chronic Lymphocytic Leukemia With 17p Deletion: The Saga Continues

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2011English

Circulating VE-cadherin in Patients With Controlled Chronic Lymphocytic Leukemia

Pathologia
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy